Clinical value of 18F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: A seven-case series and review of the literature

Modern Rheumatology

Volumn 24, Issue 4, 2014, Pages 645-650

  Yamashita, Hiroyuki ^a   Kubota, Kazuo ^a   Takahashi, Yuko ^a   Minamimoto, Ryogo ^a   Morooka, Miyako ^a   Kaneko, Hiroshi ^a   Kano, Toshikazu ^a   Mimori, Akio ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Adult onset Still's disease

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; FLUORODEOXYGLUCOSE F 18; LACTATE DEHYDROGENASE; SOLUBLE INTERLEUKIN 2 RECEPTOR; TOCILIZUMAB; RADIOPHARMACEUTICAL AGENT;

ADULT; ADULT ONSET STILL DISEASE; BLOOD VESSEL; BONE MARROW; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIAPHRAGM; DISEASE ACTIVITY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG UPTAKE; ERYTHROCYTE SEDIMENTATION RATE; EYELID; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JOINT; LYMPH NODE; MALE; MUSCLE; PERICARDIUM; PLEURA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SALIVARY GLAND; SPLEEN; AGED; CASE REPORT; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; LYMPHOMA; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; STILL'S DISEASE, ADULT-ONSET;

EID: 84903721469     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2013.850998     Document Type: Review

References (37)

1. Cagatay Y, Gul A, Cagatay A, Kamali S, Karadeniz A, Inanc M, et al. Adult-onset Still's disease. Int J Clin Pract. 2009;63(7):1050-5.
2. Pouchot J, Sampalis JS, Beaudet F, Carette S, Décary F, Salusinsky-Sternbach M, et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine. 1991; 70(2): 118-36.
3. Masson C, Le Loët X, Lioté F, Renou P, Dubost JJ, Boissier MC, et al. Adult Still's disease: part I. Manifestations and complications in sixty-five cases in France. Rev Rhum Engl Ed. 1995;62(11):748-57.
4. Hashimoto M, Shingu M, Ezaki I, YoshikawaY, Nobunaga M. Clinical studies on 14 cases of adult-onset Still's disease. Nihon Rinsho Meneki Gakkai Kaishi. 1995;18(1):45-52.
5. Uppal SS, Al-Mutairi M, Hayat S, Abraham M, Malaviya A. Ten years of clinical experience with adult onset Still's disease: is the outcome improving? Clin Rheumatol. 2007;26(7):1055-60.
6. Ben Taarit C, Turki S, Ben Maïz H. Adult Still's disease: study of a series of 11 cases. J Mal Vasc. 2002;27(1):31-5.
7. Wouters JM, van de Putte LB. Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med. 1986;61(235):1055-65.
8. Magadur-Joly G, Billaud E, Barrier JH, Pennec YL, Masson C, Renou P, Prost A. Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in West France. Ann Rheum Dis. 1995;54(7):587-90.
9. Wakai K, Ohta A, Tamakoshi A, Ohno Y, Kawamura T, Aoki R, et al. Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan. J Epidemiol. 1997;7(4):221-5.
10. Kádár J, Petrovicz E. Adult-onset Still's disease. Best Pract Res Clin Rheumatol. 2004;18(5):663-76
11. Even-Sapir E. PET/C Tinmalignant bone disease. Semin Musculoskelet Radiol. 2007;11(4):312-21.
12. Delbeke D, Martin WH. Positron emission tomography imaging in oncology. Radiol Clin North Am. 2001;39(5):883-917.
13. Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S, Bobbaers H, Mortelmans L. Clinicalvalueof[F-18]fluorodeoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis. 2001;32(2):191-6.
14. Kubota K, Nakamoto Y, Tamaki N, Kanegae K, Fukuda H, Kaneda T, et al. FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med. 2011;25(5): 355-64.
15. Funauchi M, Ikoma S, Kishimoto K, Shimazu H, Nozaki Y, Sugiyama M, Kinoshita K. A case of adult onset Still's disease showing marked accumulation in the liver and spleen, on positron emission tomography-CT images. Rheumatol Int. 2008;28(10):1061-4.
16. ⊃ F-fluoro-dexoxyglucose positron emission tomography in patients with adult-onset Still's disease: report of two cases and review of literatures. Rheumatol Int. 2010;30(12):1673-6.
17. Cunha ML, Wagner J, Osawa A, Scheinberg M. The Effect of tocilizumab on the uptake of 18FDG-PET imaging in patients with adult-onset Still's disease. Rheumatology (Oxford). 2010; 49(5):1014-6.
18. de Graaff LC, ten Broek MR, Schweitzer DH. Is Still's disease still one disease? A case of Adult-onset Still's disease showing accumulation in the carotids and the large vessels of the legs on positron emission tomography: CT images. Rheumatol Int. 2012;32(8):2487-90.
19. Cai L, Chen Y, Huang Z. Elevated FDG activity in lymph nodes as well as the spleen and liver in a patient with adult-onset still disease. Clin Nucl Med. 2012;37(10):1009-10.
20. Goerres GW, Forster A, Uebelhart D, Seifert B, Treyer V, Michel B, et al. F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Clin Nucl Med. 2006;31(7):386-90.
21. Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H, et al. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Ann Nucl Med. 2009;23(9):783-91.
22. Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol. 2004;31(11):2189-98.
23. Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum. 2005;52(6):1794-803.
24. Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med. 2003;253(3):263-75.
25. Neurath MF, Vehling D, Schunk K, Holtmann M, Brockmann H, Helisch A, et al. Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol. 2002;97(8):1978-85.
26. Vanderschueren S, Knockaert D, Adriaenssens T, Demey W, Durnez A, Blockmans D, Bobbaers H. From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med. 2003;163(9):1033-41.
27. Kanegae F, Tada Y, Ohta A, Ushiyama O, Suzuki N, Koarada S, et al. Bone marrow accumulation in gallium scintigraphy in patients with adult Still's disease. Ryumachi. 2002;42(6):872-8.
28. Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ, Kirsch CM. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J Nucl Med. 2007;48(11):1761-6.
29. Komori T, Narabayashi I, Matsumura K, Matsuki M, Akagi H, Ogura Y, et al. 2-[Fluorine-18]-Xuoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diff usion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med. 2007;21(4):209-15.
30. Chen YK, Su CT, Chi KH, Cheng RH, Wang SC, Hsu CH. Utility of 18F-FDG PET/CT uptake patterns in Waldeyer's ring for diff erentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx. J Nucl Med. 2007;48(1):8-14.
31. Jaffe ES, Ralfkiaer E. Hepatosplenic T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al. editors. World Health Organization classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 210-11.
32. Weidmann E. Hepatosplenic T-cell lymphoma. A review on 45 cases since the first report describing the disease as distinct lymphoma entity in 1990. Leukemia. 2000;14(6):991-7.
33. Murata Y, Kubota K, Yukihiro M, Ito K, Watanabe H, Shibuya H. Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT. Nucl Med Biol. 2006;3(8):999-1004.
34. Kim K, Kim SJ, Kim IJ, Kim BS, Pak K, Kim H. Diffuse increased splenic F-18 fluorodeoxyglucose uptake may be an indirect sign of acute pyogenic cause rather than tuberculous in patients with infectious spondylitis. Nucl Med Commun. 2011;32(12):1155-61.
35. Yamashita H, Kubota K, Takahashi Y, Minamimoto R, Morooka M, Kaneko H, et al. Similarities and diff erences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis. Joint Bone Spine. 2013;80(2):171-7.
36. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992;19(3):424-30.
37. Cush JJ, Medsger TA Jr, Christy WC, Herbert DC, Cooperstein LA. Adult onset Still's disease. Clinical course and outcome. Arthritis Rheum. 1987;30(2):186-94.